Featured Editorial

  1. From Passive To Predictive: The New Era Of Clinical Cold Chain Management 4/16/2026

    Temperature-sensitive drugs demand a cold chain that predicts disruptions, manages risks, and coordinates globally to keep trials on time and patients safe.

  2. When Shipments Stop: Understanding And Managing Customs Delays In Clinical Supply Chains 4/15/2026

    Customs delays aren’t random disruptions. They reveal where documentation, classification, and context fail to align under scrutiny across complex global trials.

  3. U.S. Pharma Tariffs And MFN Become Law After April 2 Update 4/15/2026

    Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.

  4. 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening 4/14/2026

    Expert-recommended "once‑in‑a‑lifetime" testing for Lp(a) introduces new clinical supply risks as screening drives volatility, longer treatment, and inventory strain.

  5. Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think 4/14/2026

    Misaligned assumptions in contracts and budgets quietly derail supply plans, driving rework, delays, and execution risk long before issues surface.

  6. From Policy To Practice: Embedding Export Compliance In Clinical Supply 4/13/2026

    Export compliance in clinical supply cannot be an afterthought. Embedding it into workflows, training, and decision making reduces risk while improving speed and coordination.

  7. What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design 4/10/2026

    Cold chain failures in ATMPs often stem from hidden design flaws, not execution errors. Learn how overlooked material, process, and preservation choices drive risk.

  8. AI And Digital Tools Advance Clinical Trial Supply Chains 4/9/2026

    AI is reshaping trial supply with smarter forecasting, risk detection, and real-time control, cutting waste, preventing delays, and turning data into decisive action.

  9. Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials 4/8/2026

    Decentralized trials promise better patient access but create major supply risks. From cold chain failures to regulatory hurdles, here is what sponsors must solve now.

  10. How The Strait Of Hormuz Crisis Is Stalling U.S. Medical Breakthroughs 4/7/2026

    Global shipping disruptions through the Strait of Hormuz are delaying investigational drugs, increasing costs, and threatening the timeline of critical U.S. clinical trials.